A review of ACS care in Central and Eastern European Transitional countries revealed substantial geographical variation, with in-hospital AMI mortality ranging from 6.3% to 15.3%.
How do quality of care and outcomes for acute coronary syndromes vary across Central and Eastern European Transitional countries?
There is substantial geographical variation in early mortality and emergency reperfusion strategies for STEMI across Central and Eastern European Transitional countries, highlighting the need for improved acute cardiac care and data collection.
AIMS: The purpose of this review was to compare quality of care and outcomes following acute coronary syndrome (ACS) in Central and Eastern European Transitional (CEET) countries. METHODS: This was a review of original ACS articles in CEET countries from PubMed, ISI Web of Science, Medline and Embase databases published in English from November 2003 to February 2014. RESULTS: Seventeen manuscripts fulfilled the search criteria. Of 19 CEET countries studied, there were no published ACS management or outcome data for four countries. In-hospital mortality for patients with acute myocardial infarction (AMI) ranged from 6.3% in the Czech Republic to 15.3% in Latvia. In-hospital mortality for ST-elevation myocardial infarction (STEMI) ranged from 3.0% in Poland to 20.7% in Romania. For STEMI, primary percutaneous coronary intervention (PCI) ranged from 1.0% to over 92.0%, fibrinolytic therapy from 0.0% to 49.6%, and no reperfusion therapy from 7.0% to 63.0%. CONCLUSION: Many CEET countries do not have published ACS care and outcomes data. Of those that do, there is evidence for substantial geographical variation in early mortality. Wide variation in emergency reperfusion strategies for STEMI suggests that acute cardiac care is likely to be modifiable and if addressed could reduce mortality from ACS in CEET countries. The collection of ACS care and outcomes data across Europe must be prioritised.
Smith et al. (2014) conducted a review in Acute coronary syndrome. A review of ACS care in Central and Eastern European Transitional countries revealed substantial geographical variation, with in-hospital AMI mortality ranging from 6.3% to 15.3%.